Search
Home
About FERRLECIT
Iron Deficiency Anemia
Professional Resource Center
Ferrlecit Support Programs
Dosing Reimbursment
Request a Rep/Order Reprints
Contact Us
Full Prescribing Information
Active Iron Management
The Drive Study
 
If you are interested in having one of our Representatives visit your office, please call our Customer Support Center at 888-EXP-IRON (option1) or fill out the
information below.(1-888-397-4766)
 

*required fields

*First Name:
*State:
*Last Name:
*Zip:
*Address:
*Telephone:
Address:
*Email:
*City:
Occupation:
 
The information pertaining to you that we collect will be used in accordance with our Privacy Policy. Your personal information will not be shared with anyone.
 
Submit
 
+ References:
 
Safety Information
FERRLECIT is contraindicated in non iron-deficient anemias, in patients hypersensitive to FERRLECIT or its inactive components, or with evidence of iron overload • Hypersensitivity reactions have been reported with injectable iron products • Hypotension has been reported with rapid administration of IV iron • In a single-dose, placebo-controlled safety study (n=1097), the most frequent adverse events occurring after FERRLECIT administration were hypotension, nausea, and vomiting and/or diarrhea • In multiple-dose studies (n=126), the most frequent adverse events, whether or not related to FERRLECIT administration, were nausea, vomiting and/or diarrhea, injection site pain, hypotension, cramps, hypertension, dizziness, dyspnea, and chest pain • Please see full prescribing information for Warnings, Precautions, and Adverse Reactions
Watson Pharmaceuticals, Inc.